Literature DB >> 24604520

MicroRNA-127-3p promotes glioblastoma cell migration and invasion by targeting the tumor-suppressor gene SEPT7.

Huawei Jiang1, Dasong Hua2, Jing Zhang2, Qing Lan3, Qiang Huang3, Jae-Geun Yoon4, Xu Han2, Lisha Li2, Gregory Foltz4, Shu Zheng1, Biaoyang Lin1.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs of 20-25 nucleotides in length that are capable of modulating gene expression post-transcriptionally. The potential roles of miRNAs in the tumorigenesis of glioblastoma (GBM) have been under intensive studies in the past few years. In the present study, we found a positive correlation between the levels of miR-127-3p and the cell migration and invasion abilities in several human GBM cell lines. We showed that miR-127-3p promoted cell migration and invasion of GBM cells using in vitro cell lines and in vivo mouse models. We identified SEPT7, a known tumor-suppressor gene that has been reported to suppress GBM cell migration and invasion, as a direct target of miR-127-3p. SEPT7 was able to partially abrogate the effect of miR-127-3p on cell migration and invasion. In addition, microarray analysis revealed that miR-127-3p regulated a number of migration and invasion-related genes. Finally, we verified that miR-127-3p affected the remodeling of the actin cytoskeleton mediated by SEPT7 in GBM cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24604520     DOI: 10.3892/or.2014.3055

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  19 in total

1.  A Novel Bioengineered miR-127 Prodrug Suppresses the Growth and Metastatic Potential of Triple-Negative Breast Cancer Cells.

Authors:  Maxine Umeh-Garcia; Catalina Simion; Pui-Yan Ho; Neelu Batra; Anastasia L Berg; Kermit L Carraway; Aiming Yu; Colleen Sweeney
Journal:  Cancer Res       Date:  2019-11-06       Impact factor: 12.701

2.  Mesenchymal stem cell-derived exosomes block malignant behaviors of hepatocellular carcinoma stem cells through a lncRNA C5orf66-AS1/microRNA-127-3p/DUSP1/ERK axis.

Authors:  Hao Gu; Chao Yan; Haijun Wan; Lin Wu; Junjie Liu; Zhiqiang Zhu; Dazhi Gao
Journal:  Hum Cell       Date:  2021-08-24       Impact factor: 4.374

3.  MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.

Authors:  Xiao Yue; Dechen Cao; FengMing Lan; Qiang Pan; Tingyi Xia; Huiming Yu
Journal:  Neuro Oncol       Date:  2016-03-22       Impact factor: 12.300

4.  MicroRNA expression profiles and target prediction in neonatal Wistar rat lungs during the development of bronchopulmonary dysplasia.

Authors:  Yujiao Xing; Jianhua Fu; Haiping Yang; Li Yao; Lin Qiao; Yanna Du; Xindong Xue
Journal:  Int J Mol Med       Date:  2015-09-17       Impact factor: 4.101

5.  Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational Study.

Authors:  Yu-Zheng Ge; Lu-Wei Xu; Zheng Xu; Ran Wu; Hui Xin; Meng Zhu; Tian-Ze Lu; Li-Guo Geng; Hao Liu; Chang-Cheng Zhou; Peng Yu; You-Cai Zhao; Zhi-Kai Hu; Yan Zhao; Liu-Hua Zhou; Jian-Ping Wu; Wen-Cheng Li; Jia-Geng Zhu; Rui-Peng Jia
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

Review 6.  Septin Mutations in Human Cancers.

Authors:  Dimitrios Angelis; Elias T Spiliotis
Journal:  Front Cell Dev Biol       Date:  2016-11-09

7.  miR-127 enhances myogenic cell differentiation by targeting S1PR3.

Authors:  Lili Zhai; Rimao Wu; Wanhong Han; Yong Zhang; Dahai Zhu
Journal:  Cell Death Dis       Date:  2017-03-30       Impact factor: 8.469

8.  The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK/ERK activation.

Authors:  Nianzhu Zhang; Lu Liu; Ning Fan; Qian Zhang; Weijie Wang; Mingnan Zheng; Lingfei Ma; Yan Li; Lei Shi
Journal:  Oncotarget       Date:  2016-09-20

9.  Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: new emerging cancer players.

Authors:  Sara Franceschi; Francesca Lessi; Paolo Aretini; Valerio Ortenzi; Cristian Scatena; Michele Menicagli; Marco La Ferla; Prospero Civita; Katia Zavaglia; Claudia Scopelliti; Alessandro Apollo; Francesco Giovanni Carbone; Riccardo Vannozzi; Generoso Bevilacqua; Francesco Pasqualetti; Antonio Giuseppe Naccarato; Chiara Maria Mazzanti
Journal:  Oncotarget       Date:  2018-05-08

10.  Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells.

Authors:  Dongchao Xu; Ajuan Liu; Xuan Wang; Yidan Chen; Yunyun Shen; Zhou Tan; Mengsheng Qiu
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.